| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |